Table 1:
PV isolation (n = 27) | LAM (n = 25) | P-value | |
---|---|---|---|
Age (years) | 56.5 ± 6.9 | 58.2 ± 7.9 | 0.123 |
Gender (female) | 16 (59.3%) | 14 (56.0%) | 0.243 |
Mean NYHA functional class | |||
II | 11 (40.7%) | 7 (28.0%) | 0.059 |
III | 16 (59.3%) | 18 (72.0%) | 0.053 |
AF paroxysms duration (months) | 18.4 ± 7.9 | 25.1 ± 11.3 | 0.091 |
History of stroke | 2 (7.4%) | 1 (3.7%) | 0.063 |
LVEF (%) | 59.2 ± 4.9 | 54.4 ± 6.7 | 0.219 |
Mean LA size (mm) | 63.6 ± 1.9 | 66.1 ± 1.5 | 0.367 |
Mitral valve lesion | |||
Rheumatic | 15 (55.6%) | 13 (52.0%) | 0.362 |
Degenerative | 10 (37.0%) | 11 (44.0%) | 0.197 |
Endocarditis | 2 (7.4%) | 1 (4.0%) | 0.063 |
Continuous data as mean ± standard deviation and categorical data as number (percentage).
LVEF: left ventricular ejection fraction; LA: left atrium; LAM: left atrial maze; PV: pulmonary vein.